Biosig cleared to test merimepodib plus remdesivir in COVID-19

Biosig cleared to test merimepodib plus remdesivir in COVID-19

Source: 
Pharmaforum
snippet: 

US biotech BioSig Technologies’ subsidiary ViralClear has been cleared by the FDA to start a phase 2 trial of its antiviral drug merimepodib in patients who are severely ill with COVID-19.